Alnylam Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,500

Employees2,500

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,500

Employees2,500

ALNY Key Statistics

Market cap

40.17B

Market cap40.17B

Price-Earnings ratio

72.48

Price-Earnings ratio72.48

Dividend yield

—

Dividend yield—

Average volume

811.40K

Average volume811.40K

High today

$305.68

High today$305.68

Low today

$300.30

Low today$300.30

Open price

$302.43

Open price$302.43

Volume

202.99K

Volume202.99K

52 Week high

$495.55

52 Week high$495.55

52 Week low

$284.28

52 Week low$284.28

Stock Snapshot

Alnylam Pharmaceuticals(ALNY) stock is priced at $300.87, giving the company a market capitalization of 40.17B. It carries a P/E multiple of 72.48.

During the trading session on 2026-05-29, Alnylam Pharmaceuticals(ALNY) shares reached a daily high of $305.68 and a low of $300.30. At a current price of $300.87, the stock is +0.2% higher than the low and still -1.6% under the high.

Trading activity shows a volume of 202.99K, compared to an average daily volume of 811.4K.

The stock's 52-week range extends from a low of $284.28 to a high of $495.55.

ALNY News

Simply Wall St 15h

How Investors May Respond To Alnylam Pharmaceuticals Adding Scientific Depth Amid RNAi Pipeline Scrutiny

Alnylam Pharmaceuticals recently expanded its Board of Directors from ten to eleven members and appointed Benjamin F. Cravatt, Ph.D., as a Class III director th...

TipRanks 2d

Alnylam Shareholders Reaffirm Board, Pay Practices and Auditor

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 6d

Assessing Alnylam Pharmaceuticals Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake

Advertisement What recent price moves tell you about Alnylam Pharmaceuticals (ALNY) Alnylam Pharmaceuticals (ALNY) has drawn investor attention after a period...

Analyst ratings

71%

of 31 ratings

Buy

71%

Hold

29%

Sell

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.

Eli Lilly

Vertex Pharmaceuticals

Taiwan Semiconductor Manu…

Novo Nordisk

Meta Platforms

Netflix

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.